Feb 22, 2019
If you are raising capital now, the path you are about to embark on can be stressful and littered with obstacles, but the light at the end of the tunnel is worth the trials and tribulations. Despite the inherent challenges of fundraising, the current climate is quite...
Nov 15, 2017
The JP Morgan Healthcare Conference, or “JPM”, is the healthcare conference of the year. Companies from all over the world convene in San Francisco to setup meetings with investors, prospective partners, service providers, etc. and lay the groundwork for much of the...
Aug 15, 2017
A few months ago, I posted a related article about deal timing titled ‘Maintaining Deal Momentum in the Summer Months’. Now it is early August, and we are deep in the summer slowdown. Many of us are enjoying the last stints of our summer holidays before returning to...
Mar 2, 2017
The FDA Amendments Act of 2007 created an incentive system for drug developers to pursue tropical neglected diseases, whereby upon approval of a product for a designated tropical disease, the drug developer would receive a voucher that could be applied to receive a...
Feb 22, 2017
This has certainly been an eventful few months for Immunomedics and its largest shareholder, venBio. In case you haven’t been following, below is a brief replay: Towards the end of last year, venBio, the beneficial owner of approximately 9.9% of the outstanding...
Feb 15, 2017
It has happened. After years of blood, sweat, and tears, the lead compound has made it to Phase 3 pivotal studies. Patients, physicians, the company team and investors all wait patiently for recruitment to complete and data to be collected, hoping to improve patient...
